The impact of Exercise on Chemotherapy Symptoms in cancer patients
- Conditions
- Drug-Related Side Effects and Adverse Reactions
- Registration Number
- RBR-25g4gt6
- Lead Sponsor
- niversidade Estadual do Centro Oeste
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Adult patients (above 18 years old) undergoing chemotherapy treatment. Patients diagnosed with solid cancer who require regular chemotherapy infusions. Adequate physical condition to perform aerobic exercise during the infusion, as assessed by a healthcare professional. Ability to understand and follow study instructions. Availability to regularly participate in chemotherapy sessions during the study period.
Patients with medical contraindications for engaging in physical exercise. Presence of severe medical conditions, in addition to cancer, that may interfere with participation in the study or the ability to perform exercises during the infusion. Significant physical incapacity that hinders the safe execution of exercises. History of serious cardiac problems or recent cardiac events. Participation in other research studies simultaneously. Psychological or emotional conditions that may negatively affect participation in the study or adherence to the exercise protocol.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A minimum variation of 15% in pre- and post-intervention scores is anticipated. Additionally, qualitative reports from patients regarding their perception of their quality of life will be considered. Statistical analysis will employ appropriate tests, such as ANOVA, to identify statistically significant differences between the groups. Data collection, conducted throughout the treatment, will utilize the EORTC QLQ C30 questionnaire to measure quality of life. Parameters will include overall quality of life scores, levels of fatigue, presence of symptoms such as nausea and pain, and functional capacity.
- Secondary Outcome Measures
Name Time Method